The story of copyright's flagship drug presents a complex case for observers in the drug sector. While initially a tremendous success, generating vast sums, the exclusivity lapse and the subsequent arrival of off-brand https://adult912806.prublogger.com/40596606/the-little-copyright-and-big-pharma-a-risky-investment